Key statistics
On Friday, Pliant Therapeutics Inc (9PT:STU) closed at 10.80, 13.09% above the 52 week low of 9.55 set on Jul 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.10 |
---|---|
High | 11.10 |
Low | 10.80 |
Bid | 10.70 |
Offer | 11.10 |
Previous close | 11.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 60.80m |
Free float | 59.01m |
P/E (TTM) | -- |
Market cap | 738.13m USD |
EPS (TTM) | -3.09 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Announcements
- Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024
- Pliant Therapeutics to Participate in Upcoming Investor Events
- Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024
- Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple Measures
- Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
- Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™
- Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
More ▼